New agreement to accelerate nutrition testing worldwide
Trajan Nutrition has signed a memorandum of understanding (MOU) with the South Australian Health and Medical Research Institute (SAHMRI) to accelerate the translation in the global market of nutrition testing research led by Professors Maria Makrides and Robert Gibson.
Trajan Scientific and Medical established Trajan Nutrition in 2017 as a joint venture with Prof Makrides and Prof Gibson. Under the new agreement, Trajan Nutrition and SAHMRI will leverage the know-how and the expertise of the SAHMRI Nutrition Laboratory — an analytical testing and research laboratory entirely dedicated to nutrition tests, claimed to be the biggest and best-equipped in the Asia–Pacific region.
“This new agreement will support Trajan Nutrition in offering tailored solutions and technologies for nutrition testing on a global scale, in partnership with research organisations, pathology laboratories, food and supplement companies, health insurance and corporate wellness providers,” said Trajan Nutrition’s newly appointed CEO, Marco Baccanti.
Professor Steve Wesselingh, Executive Director of SAHMRI, added, “This agreement with Trajan Nutrition is an important example of SAHMRI’s strategy to deliver translation of the results of its medical research activities into therapeutic solutions for patients and better preventative health approaches.”
Trajan Scientific and Medical continues to develop partnerships with unique collaboration models with academia, industry experts and like-minded organisations. The company’s CEO, Stephen Tomisich, concluded, “This marks an important milestone to accelerate our progress with Trajan Nutrition and, more broadly, with the adoption of Trajan’s microsampling technologies, a stronger focus on proactive wellness through patient-centric and delocalised health care.”
Please follow us and share on Twitter and Facebook. You can also subscribe for FREE to our weekly newsletters and bimonthly magazine.
Vaxxas to advance its microarray patches for COVID vaccination
Vaxxas will receive AU$3.2m from BARDA to accelerate work advancing its high-density microarray...
Global competition targets 'undruggable' cancer protein
A new global competition offering over US$500,000 in prizes aims to spur drug discovery...
SMi Systems appoints Dr Ankur Mutreja as Senior Advisor
Mutreja was previously Head of Global South Partnerships at CEPI, where he was responsible for...
